Gel for the treatment of herpes lip lesions

Phase 2

Recruiting

• Conditions: Herpetic Stomatitis; Herpes Simplex; Perioral herpes.; C02.256.466.382.316; Lip herpes; HSV-1; C02.256.466.382.834; C02.256.466.382; B04.280.382.100.750.390

• Registration Number: RBR-4kkq8c
• Lead Sponsor: Faculdade De Odontologia de Ribeirão Preto

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-10
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Legal or minor adult volunteers with accompanying legal guardians; both genders; without current treatment regimen against herpes.

Exclusion Criteria

Individuals in use or who used systemic-specific antiviral medication in the 15 days preceding the study;pregnant women;patients with heart disease.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected that patients treated with the application of the film-forming semisolid composition will benefit from the remission of signs and symptoms of herpes labialis lesions within 24 to 72 hours after initiation of treatment.

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected